Nicolas Palaskas, MD (@palaskasn) 's Twitter Profile
Nicolas Palaskas, MD

@palaskasn

Cardiooncologist @MDAndersonNews Father, Husband, Runner. Views expressed are my own.

ID: 1083238067593510912

calendar_today10-01-2019 05:44:15

124 Tweet

582 Followers

290 Following

Caroline Chung, MD (@ca_chung) 's Twitter Profile Photo

FACD = Faculty Academic Career Development ⁦MD Anderson Cancer Center⁩ - starting out journey to build data literacy - one acronym and concept at a time! 😊 ⁦Dr Phyu P Aung⁩ ⁦Cullen Taniguchi, MD⁩ ⁦Nicolas Palaskas, MD⁩ & Marta Davila #ContextEngine

FACD = Faculty Academic Career Development ⁦<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>⁩ - starting out journey to build data literacy - one acronym  and concept at a time! 😊 ⁦<a href="/DrPhyuPAung2/">Dr Phyu P Aung</a>⁩ ⁦<a href="/TaniguchiMD/">Cullen Taniguchi, MD</a>⁩ ⁦<a href="/PalaskasN/">Nicolas Palaskas, MD</a>⁩ &amp; Marta Davila #ContextEngine
Caroline Chung, MD (@ca_chung) 's Twitter Profile Photo

Thank you Anne Tsao, MD, MBA & team for the opportunity to work with our faculty to work on data quality & data literacy projects over the next year to enable #datadriven decisions & enhance the power of #DataScience MD Anderson Cancer Center

Karine Tawagi MD (@drkarinetawagi) 's Twitter Profile Photo

Join Dr. Michael Ong & I this Friday Sept 30 for the inaugural Canadian Advances in Managing Immuno-Oncology conference! Experts will discuss best practices around #irAE dx & mgmt w/ case presentations. Registration is free: bit.ly/3Cb8qxV. Agenda & speakers below.

Join Dr. Michael Ong &amp; I this Friday Sept 30 for the inaugural Canadian Advances in Managing Immuno-Oncology conference!

Experts will discuss best practices around #irAE dx &amp; mgmt w/ case presentations. Registration is free: bit.ly/3Cb8qxV. Agenda &amp; speakers below.
Adam Potter, MD, PhD, FACC (@adampottermdphd) 's Twitter Profile Photo

JACC Specialty Journals - JACC: CardioOncology - Outcomes of Stroke and Bleeding by Class of Anticoagulant Use For NVAF In Patients With Active Cancer #cardioonc ⁦Nicolas Palaskas, MD⁩ ⁦Anita Deswal⁩ ⁦⁦OhioStateDHLRI⁩ ⁦MD Anderson Cancer Center⁩ podcasts.google.com/feed/aHR0cHM6L…

Jennifer Anderson (@jennannet) 's Twitter Profile Photo

Calling all MD Anderson Cancer Center faculty! Stop by the CAO Pop-Up (Pickens Tower skybridge entrance) this afternoon, Oct 27th, 1-4p to meet the Academic Career Development Committees and learn what your committee is up to, how to get involved, grab some snacks & a souvenir. #EndCancer

Calling all <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> faculty! Stop by the CAO Pop-Up (Pickens Tower skybridge entrance) this afternoon, Oct 27th, 1-4p to meet the Academic Career Development Committees and learn what your committee is up to, how to get involved, grab some snacks &amp; a souvenir. #EndCancer
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Ever wondered what is the best #anticoagulant is best for #cancer patients with #AFib? #DOAC and #warfarin have similar risks for CVA, ICH, & GIB for #NVAF. bit.ly/3sUdfGo #JACCCardioOnc #CardioOnc #CardioTwitter Adam Potter, MD, PhD, FACC Efstratios Koutroumpakis, MD Anita Deswal Nicolas Palaskas, MD

Ever wondered what is the best #anticoagulant is best for #cancer patients with #AFib? #DOAC and #warfarin have similar risks for CVA, ICH, &amp; GIB for #NVAF. bit.ly/3sUdfGo

#JACCCardioOnc #CardioOnc #CardioTwitter <a href="/AdamPotterMDPhD/">Adam Potter, MD, PhD, FACC</a> <a href="/EKoutroumpakis/">Efstratios Koutroumpakis, MD</a> <a href="/anita_deswal/">Anita Deswal</a> <a href="/PalaskasN/">Nicolas Palaskas, MD</a>
MD Anderson Cancer Center (@mdandersonnews) 's Twitter Profile Photo

"The upfront use of immunomodulatory therapy is increasingly being explored," says our Dr. Nicolas Palaskas of a new approach to treating myocarditis. fal.cn/3wj9f Nicolas Palaskas, MD Medscape #EndCancer

ACC Media Center (@accmediacenter) 's Twitter Profile Photo

Dr. @Anita_Deswal on the STOP-CA findings, “In the cardio-oncology space, double-blind, randomized, placebo-controlled studies are sparse and infrequent, so to get this trial done is a major feat.” #ACC23/#WCCardio

Dr. @Anita_Deswal on the STOP-CA findings, “In the cardio-oncology space, double-blind, randomized, placebo-controlled studies are sparse and infrequent, so to get this trial done is a major feat.” #ACC23/#WCCardio